Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirzepatide for Treatment of CCCA
NCT07734870Phase 2Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Sep 2026
- Primary completion
- May 2028
- Countries
- 1
01
Overview
A Phase 2 trial of tirzepatide in central centrifugal cicatricial alopecia (CCCA), sponsored by Johns Hopkins University. Started Sep 2026; status: recruiting.
02
Drugs
03
Conditions
central centrifugal cicatricial alopecia (CCCA)
Beyond the preview
Go deeper on NCT07734870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07734870.